Latest Story
VCU tests third COVID-19 drug, this time targeting inflammation
Researchers hope drug will help subset of patients with pneumonia, cytokine release syndrome
Researchers at VCU Health now are conducting trials on a third drug to help treat COVID-19, a medication that suppresses inflammation in people with a type of juvenile arthritis. Canakinumab
